BNP Paribas Exane cuts Pepsico stock price target on demand woes

BNP Paribas Exane cut PepsiCo's price target to $161 from its prior target while retaining an Outperform rating, citing persistent North American demand weakness ahead of Q3 results on October 8. The firm expects FY2026 EPS of $8.55 at the low end of guidance and sees PepsiCo missing its prior ambition to reach the high end of 2%-4% organic-sales growth in the second half. Higher costs, limited pricing flexibility, investment requirements and Russia exposure cloud FY2027, although mid-single-digit international growth, productivity gains and a 4.51% dividend yield provide support.

Analysis

PEP’s valuation support is real only if North American volume/mix stabilization is visible by the October print. At the current multiple, the market is already discounting a weak domestic franchise, but not a multi-quarter reset in which promotional spending rises while input costs limit gross-margin recovery. The key debate is therefore not FY26 EPS delivery; it is whether FY27 consensus still embeds an attainable margin and organic-growth exit rate.

International growth can cushion earnings but does not fully solve the multiple problem: it carries greater FX, geopolitical and local-input volatility and is less likely to command the same valuation as a recovering U.S. snacks/beverages business. Russia exposure is likely immaterial to the next quarter but raises the probability of discrete charges or trapped-cash noise, while constrained pricing power makes commodity inflation more damaging than in prior pricing-led cycles. A negative read-through would extend to packaged-food peers with similarly stretched volume elasticity, notably KHC, GIS and CPB, although their company-specific turnaround paths differ.

The contrarian setup is that PEP may be nearer a tradable low than a structural short: a low-end guide outcome is broadly anticipated, the dividend limits downside for long-only holders, and evidence that promotions are defending unit velocity could trigger a relief rally. That said, a rerating requires management to show that productivity funds reinvestment rather than merely offsets inflation. Near-term, the October earnings call is the catalyst; over 1-3 months, scanner data and FY27 framing matter more than a modest third-quarter beat.

Falsification for the cautious view is sustained North American volume improvement without a deterioration in gross margin, coupled with unchanged FY27 margin targets. Conversely, a guide cut, a material step-up in promotional investment, or gross-margin compression despite productivity would validate further downside and likely pull the stock below its recent trading floor.

Key Decisions for Investors

• Maintain an underweight in PEP into the October 8 result; do not initiate an outright short at current depressed levels. Reassess after earnings: a break below the recent low following an FY27 margin reset offers a cleaner downside entry, targeting a further 8-12% move versus a 5-6% stop on restored guidance.
• For a defined-risk bearish expression through the event, consider a PEP 1-3 month put spread only if implied volatility remains below the expected post-earnings move. The trade requires confirmation that option skew has not already priced a guidance-cut scenario.
• Watch North American scanner volumes, promotional intensity and gross-margin commentary rather than headline EPS. A sequential volume improvement with stable gross margin would be a signal to cover bearish exposure and consider a tactical long for a 5-8% relief rally.
• Use a relative-value screen versus KHC, GIS and CPB after earnings. Prefer long PEP versus a weaker-volume peer only if PEP demonstrates domestic stabilization; absent that evidence, PEP’s dividend yield is not sufficient compensation for FY27 estimate-risk.